Chronic liver diseases, if left untreated, can pose serious health issues, as they can quietly progress and result in severe liver damage, or even liver failure. The effective management of these disorders depends on early recognition and ongoing monitoring. The gold standard for evaluating liver function was formerly liver biopsy; however, the development of non-invasive FibroScan liver test technology has completely changed the way chronic liver diseases are monitored and managed. This blog will discuss the application of FibroScan in the treatment of chronic liver diseases, emphasizing how it may be used to track the progression of liver fibrosis, evaluate the buildup of fat, and guide treatment decisions. We’ll explore how it’s used to treat cirrhosis, fatty liver disease, and hepatitis, as well as how it became an indispensable tool in hepatology.

FibroScan in the management of Hepatitis

Hepatitis is a major contributor to chronic liver diseases, especially hepatitis B and C. These viral infections damage and inflame the liver cells, which can result in cirrhosis, liver cancer, and fibrosis. To determine the degree of fibrosis and guide treatment decisions, routine liver health monitoring is part of the management of hepatitis.

Monitoring fibrosis in hepatitis patients

Because FibroScan offers a non-invasive way to track liver fibrosis, it is essential to the therapy of hepatitis. Regular evaluations are possible with FibroScan, negating the need for hospital stays or recuperation periods. FibroScan measures liver stiffness to identify early indicators of fibrosis even prior to the onset of symptoms. Because it enables medical professionals to start antiviral therapy or other measures to limit the course of liver damage, early identification is essential. FibroScan can be used to track the efficacy of antiviral medication in patients since a reduction in liver stiffness may signify a reduction in fibrosis.

Guiding treatment decisions

The results of a fibroscan are essential in deciding which course of treatment is best for hepatitis patients. For example, the degree of liver fibrosis affects the selection and course of antiviral medication for hepatitis C. Advanced cirrhosis or fibrosis patients can need more stringent care and constant observation. In a similar vein, the degree of fibrosis in hepatitis B can influence when antiviral medication should be started as well as how likely it is that problems like liver cancer would arise. FibroScan lets doctors customize treatment strategies for individual patients, improving results and lowering the risk of over- or under-treating patients by offering reliable and repeatable assessments of liver stiffness.

FibroScan in the management of Fatty Liver Disease

The increase in obesity and metabolic syndrome has led to an increasing public health concern over fatty liver disease, including non-alcoholic fatty liver disease (NAFLD). An accumulation of fat in the liver is a characteristic of non-alcoholic steatohepatitis (NASH), which can lead to fibrosis and ultimately cirrhosis. Alcohol-related fatty liver disease progresses similarly and is associated with overindulgence in alcohol.

Assessing liver fat and fibrosis

FibroScan is a vital tool in the treatment of fatty liver disease since it uses the Controlled Attenuation Parameter (CAP) to quantify liver fat content in addition to measuring liver stiffness. In patients with alcohol-related liver disease or nonalcoholic fatty liver disease (NAFLD), this dual capacity enables a thorough evaluation of liver health. The liver’s steatosis, or buildup of fat, is estimated by the CAP score, and the amount of fibrosis is shown by the liver stiffness measurement. Determining the probability of developing NASH or cirrhosis and staging the illness depend on this information. Significant fibrosis and steatosis increase the risk of liver-related problems in patients and necessitate more stringent care.

Monitoring disease progression and response to treatment

As fatty liver disease doesn’t show symptoms in its early stages, controlling it might be difficult. Patients frequently don’t show any symptoms until their illness has evolved to the point of severe cirrhosis or fibrosis. Regular monitoring of liver health is made possible by FibroScan, which permits early disease progression identification. FibroScan is a way for individuals receiving pharmacological therapy or life>

FibroScan in the management of Cirrhosis

This is the last stage of chronic liver illnesses, which is marked by a large amount of fibrosis and the development of scar tissue that alters the normal structure and function of the liver. The liver’s capacity to regenerate is drastically reduced when cirrhosis sets in, which increases the risk of liver cancer and other consequences such as portal hypertension and liver failure.

Assessing the severity of cirrhosis

FibroScan is used to measure liver stiffness in individuals with established cirrhosis since it is correlated with the degree of fibrosis. Although a liver biopsy can yield comprehensive insights into the histology of the liver, its invasiveness makes it impractical for routine surveillance. When evaluating liver stiffness, FibroScan provides a safer option. this is crucial for cirrhotic individuals since they run the risk of developing problems. FibroScan can also assist in the stratification of patients according to their propensity for problems. For example, individuals with extremely high liver stiffness scores are more likely to develop severe portal hypertension, which raises the risk of ascites, hepatic encephalopathy, and variceal haemorrhage. The prompt implementation of preventative interventions, such as beta-blockers to lower portal pressure or endoscopic surveillance for varices, is made possible by the identification of these high-risk individuals.

Monitoring for disease progression and complications

Since cirrhosis is a dynamic illness, it’s critical to evaluate it often in order to spot changes in liver stiffness that might be signs of the disease’s progression. FibroScan offers a non-invasive way to monitor liver function over time, enabling prompt treatment if the condition gets worse. FibroScan can assist in identifying the shift from compensated cirrhosis, a more severe stage marked by problems such as jaundice, ascites, and hepatic encephalopathy, in people whose liver still works normally despite fibrosis. Decompensation must be identified early because it necessitates emergency care and may lead to the discussion of liver transplantation. FibroScan can also be used to track the effectiveness of therapies meant to lessen fibrosis, including life>

Guiding clinical decisions

Clinical decision-making in cirrhosis patients is heavily reliant on the findings of fibroScans. For instance, the degree of liver stiffness may have an impact on when patients with cirrhosis should undergo monitoring for hepatocellular carcinoma (HCC), a kind of liver cancer. Individuals who score highly on hepatic stiffness are more likely to develop HCC and may need more regular imaging tests to find tumours early on. FibroScan can also help in liver transplant decision-making. Individuals who have acquired problems such refractory ascites or hepatic encephalopathy may be evaluated for transplantation if they have severe cirrhosis and high liver stiffness scores. FibroScan assists physicians in making well-informed decisions on the necessity and timing of liver transplantation by offering a non-invasive assessment of liver fibrosis.

FibroScan is a ground-breaking tool for treating chronic liver illnesses. FibroScan’s real-time data capacity allows doctors to evaluate the efficacy of interventions, customize treatment plans, and make well-informed decisions, particularly given the increasing incidence of liver disorders. Because it is non-invasive, healthcare professionals can better monitor the course of the illness and prevent severe liver damage and invasive operations, which in turn improves patient outcomes and quality of life. The FibroScan liver test is a vital component of Mission Gastro Hospital’s all-inclusive liver treatment offerings. With the use of this cutting-edge technology, liver illnesses may be accurately diagnosed and effectively managed through early identification. FibroScan is used by the hospital’s skilled staff to deliver individualized care, guaranteeing that every patient receives the best possible care and monitoring for their condition, improving both the standard of care and the patient experience.

Resource: Read more